Bioethics. 2020 Feb;34(2):166-171. doi: 10.1111/bioe.12456. Epub 2018 Jul 3.
In 2015, the Chinese pharmacologist, Tu Youyou, was awarded the Nobel Prize for Physiology or Medicine for the discovery of artemisinin. Traditional Chinese medicine (TCM) was the source of inspiration for Tu's discovery and provides an opportunity for the world to know more about TCM as a source of medical knowledge and practice. In this article, the value of TCM is evaluated from an ethical perspective. The characteristics of 'jian, bian, yan, lian' are explored in the way they promote accessibility and economic efficiency for TCM. The article also examines how the increased use and prevalence of TCM reflects the scientific, cultural, and ethical values of TCM and their increasing attraction in meeting major challenges to medicine and health systems currently and in the future. The article discusses safety issues within TCM, which is a controversial area, and also comments on some shortcomings and challenges which pose difficulties for more widespread and greater uptake of TCM-derived clinical or therapeutic interventions. The article concludes that TCM is generally safe if it is used according to TCM theory and where such applications are cognizant of the strengths and weaknesses of TCM. TCM has important bioethical values which may inform potential measures for meeting challenges facing global health care systems and the article argues that it can have an increasing role in improving human health.
2015 年,中国药理学家屠呦呦因发现青蒿素而获得诺贝尔生理学或医学奖。中医药是屠呦呦发现的灵感来源,为世界提供了更多了解中医药作为医学知识和实践来源的机会。本文从伦理角度评价了中医药的价值。探讨了“简、便、验、廉”在促进中医药可及性和经济效益方面的特点。文章还考察了中医药的广泛应用和流行如何反映了中医药的科学、文化和伦理价值观,以及它们在应对当前和未来医学和卫生系统主要挑战方面日益增加的吸引力。本文讨论了中医药安全性问题,这是一个有争议的领域,并对一些缺点和挑战进行了评论,这些缺点和挑战给更广泛和更大程度地采用基于中医药的临床或治疗干预措施带来了困难。本文的结论是,如果中医药的应用符合中医药理论,并且认识到中医药的优势和劣势,那么中医药通常是安全的。中医药具有重要的生物伦理价值,可能为应对全球医疗保健系统面临的挑战提供潜在措施,本文认为中医药可以在改善人类健康方面发挥越来越大的作用。